Skip to product information
1 of 4

Royal Algo V2 MetaTrader4 Version Lifetime Access with Updates

Royal Algo V2 MetaTrader4 Version Lifetime Access with Updates

Regular price $47.00 USD
Regular price $199.00 USD Sale price $47.00 USD
Sale Sold out
Choose Plan

 

What's Included?

✔️ Royal Algo Indicator for TradingView

✔️Non-Repainting Signals
✔️ Real-time chart signals & mobile notifications
✔️ Installation Guidelines
✔️ Works with all Timeframes and is compatible with all Currency Pairs, Cryptocurrency, and Stocks on TradingView
✔️ 24/7 support available.

How To Request Your Free Trial

To have access to a free trial, please e-mail us your TradingView username at royaltradingalgo@gmail.com

If you think Royal Algo will help you in the long run, purchase Lifetime Access at a discount, as changes in pricing will be in effect soon!

Don’t forget to invite your trader friends and family to take our free trial!

FAQ

Is the free trial similar to the paid version?

- Yes, you will get all features that come with the paid version, including the strategy.

Beginner-Friendly?

Royal Algo is designed to be a beginner-friendly indicator.

Don't know where to start? Follow the steps below.

1. Open the TradingView platform on your browser, download the app on your mobile device, and then create a free account.

2. Email us your TradingView username to receive a free 7 days of access.

3. Follow the user guide located on the website menu.

4. Find a paper trading/demo account broker to practice your trade execution. We recommend the MetaTrader 4 app for forex, cryptocurrency, and many more. For stocks, research whichever is available in your country.

That's about it! What are you waiting for? Try us out. NO RISK!


Note:

All purchases are not recurring charges, you won't get charged again when access has expired. 

TradingView subscription is separate. However, you can use the free account to run Royal Algo. You may choose to upgrade if you want to use more features like more alerts.

 

Copyright © 2023 Royal Algo Team. All rights reserved.

View full details